Protext Pharma, Inc. F.K.A. Protext Mobility , operates two wholly owned subsidiaries Plandai Biotechnology South Africa PTY LTD. and Cannabis Biosciences, Inc. The Company is engaged in the research and clinical testing of bioceutical products, all natural ingredients formulated for pharmaceutical applications and processed under pharma grade conditions. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Plandai Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Our initial product, Phytofare Catechin Complex, has been clinically shown to have times greater bioavailability over generic catechin extracts. Cannabis Biosciences is actively pursuing government licenses and permits that will allow it to use its proprietary processing and extraction technology to commence investigations and produce a full profile cannabis extract, one that contains both CBD and the precursor acid form of THC THC A and THC B found in live cannabis plant. The Company s investigations will be designed to show that the Cannabis Biosciences extraction process, which will use live leaf and low temperatures to extract the phyto chemicals, should leave the acid forms of THC intact, resulting in a non psychoactive extract with full medicinal potential and having the heightened bioavailability of other Phytofare extracts.
Quote | Protext Mobility Inc (OTCMKTS:TXTM)
Last: | $0.0018 |
---|---|
Change Percent: | -2.22% |
Open: | $0.00184 |
Close: | $0.0018 |
High: | $0.00184 |
Low: | $0.0018 |
Volume: | 600,000 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Protext Mobility Inc (OTCMKTS:TXTM)
WILMINGTON, DE / ACCESSWIRE / July 28, 2023 / Protext Mobility, Inc (OTC:TXTM) announces today as follows: Inventory On December 15, 2022, the Company's President and Chairman of the Board contributed approximately 15,000,000 Genus Cannabis Sativa Seeds (the "Seeds") to the Company as an equi...
Miami, Florida, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Protext Mobility, Inc (OTC PINK: TXTM) - On November 11, 2022, the OTCMarkets placed a caveat emptor designation on the Company’s trading symbol. The Company has issued the following Official Company Statement to update its shar...
Message Board Posts | Protext Mobility Inc (OTCMKTS:TXTM)
Subject | By | Source | When |
---|---|---|---|
They really need a psychiatric assessment I think | Murphydog25 | investorshub | 04/30/2023 4:01:06 PM |
Dr. J still posting nonsense on Twitter, it | Serpico2005 | investorshub | 04/30/2023 11:51:10 AM |
Thank you so much. XRP sounds compelling. | Stockfun1 | investorshub | 04/29/2023 11:24:23 PM |
Stockfun1 all of the coins that I mentioned? | MeLotsOfMoney | investorshub | 04/29/2023 2:34:38 PM |
MLOM.What is the current or future use cases | Stockfun1 | investorshub | 04/29/2023 1:59:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Protext Mobility Inc Company Name:
TXTM Stock Symbol:
OTCMKTS Market:
WILMINGTON, DE / ACCESSWIRE / July 28, 2023 / Protext Mobility, Inc (OTC:TXTM) announces today as follows: Inventory On December 15, 2022, the Company's President and Chairman of the Board contributed approximately 15,000,000 Genus Cannabis Sativa Seeds (the "Seeds") to the Company as an equi...
Miami, Florida, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Protext Mobility, Inc (OTC PINK: TXTM) - On November 11, 2022, the OTCMarkets placed a caveat emptor designation on the Company’s trading symbol. The Company has issued the following Official Company Statement to update its shar...
--News Direct-- Protext Mobility, Inc. (OTC PINK: TXTM) and RSAMMDA LLC (Delaware) (“RSAMMDA.LLC”) are pleased to provide the following shareholder update and announce an initial order for 2.33 million pounds of Genus Cannabis Sativa under a supply agreement. Dr. Ahmed...